Original language | English |
---|---|
Pages (from-to) | 764-768 |
Number of pages | 5 |
Journal | Journal of Geriatric Oncology |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - Jun 2020 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Geriatric Oncology, Vol. 11, No. 5, 06.2020, p. 764-768.
Research output: Contribution to journal › Short survey › peer-review
TY - JOUR
T1 - Caring for older adults with multiple myeloma during the COVID-19 Pandemic
T2 - Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma
AU - Mian, Hira
AU - Grant, Shakira J.
AU - Engelhardt, Monika
AU - Pawlyn, Charlotte
AU - Bringhen, Sara
AU - Zweegman, Sonja
AU - Stege, Claudia A.M.
AU - Rosko, Ashley E.
AU - von Lilienfeld-Toal, Marie
AU - Wildes, Tanya M.
N1 - Funding Information: ME: Grant support from German Cancer Aid (DKH). Funding Information: SJG:receives research support from National Heart Lung and Blood Institute (Grant No: 5T32HL007093 ), PI: Janis L. Abkowitz. Funding Information: Dr. Kah Poh (Melissa) Loh for her Editorial review. >[Table presented], HM: Honoraria/Consultancy fees: Amgen, Celgene, Takeda, Janssen, Sanofi. SJG:receives research support from National Heart Lung and Blood Institute (Grant No: 5T32HL007093), PI: Janis L. Abkowitz. ME: Grant support from German Cancer Aid (DKH). CP: Honoraria/Consultancy fees: Amgen, Celgene, Takeda, Janssen. SB: reports honoraria from Amgen, Bristol-Myers Squibb, Celgene, and Janssen; and reports a consultancy/advisory role for Celgene, Janssen, Karyopharm, and Takeda. SZ: research support from Janssen, Celgene and Takeda; serves in advisory boards for Janssen, Celgene and Takeda. CS: No conflicts reported. AR: Research Funding: Janssen, Regeneron, Millenium., MLT: Honoraria/Consulting fees: Celgene, Janssen, Takeda, Amgen, Oncopeptides, Cancer Drug Development Forum, Gilead, Merck, BMS, Research Funding: Celgene, Gilead, Novartis, Deutsche Krebshilfe (German Cancer Aid). TW: Research Funding: Janssen; Consulting: Carevive Systems, Seattle Genetics.
PY - 2020/6
Y1 - 2020/6
UR - http://www.scopus.com/inward/record.url?scp=85083734470&partnerID=8YFLogxK
U2 - 10.1016/j.jgo.2020.04.008
DO - 10.1016/j.jgo.2020.04.008
M3 - Short survey
C2 - 32331928
AN - SCOPUS:85083734470
SN - 1879-4068
VL - 11
SP - 764
EP - 768
JO - Journal of Geriatric Oncology
JF - Journal of Geriatric Oncology
IS - 5
ER -